TrianecT develops StrokePointer, a portable diagnostic tool that acquires and automatically analyzes electrical brain activity (EEG) in ambulances. This technology enables emergency medical services to triage large vessel occlusion stroke patients directly to appropriate treatment centers. By providing rapid, accurate assessment at the point of care, the system significantly reduces treatment delays and improves patient outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Delays in stroke diagnosis and triage often lead to patients being transported to hospitals lacking specialized endovascular treatment, resulting in significant delays in receiving critical care. This misdirection prolongs the time to treatment, exacerbating brain damage and negatively impacting patient outcomes.
Solution
TrianecT's StrokePointer™ is a portable diagnostic device designed for use in ambulances, enabling rapid and accurate stroke detection through the analysis of electrical brain activity (EEG). By providing emergency medical services (EMS) personnel with real-time diagnostic information, StrokePointer™ facilitates direct transport of patients to hospitals equipped for endovascular treatment. This streamlined triage process aims to reduce treatment delays, minimize brain damage, and improve overall patient outcomes by ensuring patients receive the appropriate care without unnecessary transfers.
Target Audience
The primary target audience includes emergency medical services (EMS) personnel and healthcare providers involved in stroke patient triage and transportation.
Features
- Portable EEG device designed for rapid stroke diagnosis in pre-hospital settings.
- Automated analysis of electrical brain activity to detect stroke indicators.
- User-friendly interface for fast application by EMS personnel.
- Enables accurate triage of stroke patients, directing them to the appropriate hospital for treatment.
- Compact and robust design suitable for use in ambulances.